BACTIGUARD HLDG B
Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management … Read more
BACTIGUARD HLDG B (5JE) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, BACTIGUARD HLDG B (5JE) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BACTIGUARD HLDG B - Net Assets Trend (None–None)
This chart illustrates how BACTIGUARD HLDG B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BACTIGUARD HLDG B (None–None)
The table below shows the annual net assets of BACTIGUARD HLDG B from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to BACTIGUARD HLDG B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
BACTIGUARD HLDG B Competitors by Market Cap
The table below lists competitors of BACTIGUARD HLDG B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
$19.20 Million |
|
Panjawattana Plastic Public Company Limited
BK:PJW
|
$19.20 Million |
|
Likhitha Infrastructure Limited
NSE:LIKHITHA
|
$19.20 Million |
|
Future Battery Minerals Ltd
AU:FBM
|
$19.21 Million |
|
Geekay Wires Limited
NSE:GEEKAYWIRE
|
$19.18 Million |
|
Zero Gravity Solutions Inc
PINK:ZGSI
|
$19.17 Million |
|
Asflow Co. Ltd.
KQ:159010
|
$19.16 Million |
|
CNTus Sungjin Co. Ltd.
KQ:352700
|
$19.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BACTIGUARD HLDG B's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares BACTIGUARD HLDG B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently BACTIGUARD HLDG B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares BACTIGUARD HLDG B's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BACTIGUARD HLDG B (5JE) | €- | N/A | N/A | $19.18 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |